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A B S T R A C T
Polyethyleneimine-coated double-walled carbon nanotubes (DWCNTs) were used for dual
gene and drug delivery, after loading the DWCNTs with the drug chloroquine, a lysosomo-
tropic compound that is able to promote escape from the lysosomal compartment. Differ-
ent forms of functionalization of the DWCNTs were examined in order to optimize this
system. They included the testing of different treatments on DWCNTs to optimize the load-
ing and delivery of chloroquine and the selection of a cationic polymer for coating the
DWCNTs for optimum DNA binding and delivery. An acid oxidation treatment of DWCNTs
was selected for optimum chloroquine loading together with polyethyleneimine as opti-
mum cationic coating agent for plasmid DNA binding. Optimization of the conditions for
choroquine-enhanced gene delivery were developed using luciferase expression as a model
system. We have demonstrated that chloroquine-loading increases the ability of polyethyl-
eneimine-coated DWCNTs to deliver functional nucleic acid to human cells. Cell viability
tests have shown no cytotoxicity of the functionalized DWCNTs at the concentrations
needed for optimum gene delivery. These results support the potential applications of this
methodology in gene therapy.
1. Introduction
Carbon nanotubes (CNTs) emerged as a new tool in nanobio-
technology and nanomedicine, particularly since new func-
tionalization methods were carried out to enhance their
biocompatibility and develop novel medical therapeutics
[1,2]. One of the most promising applications of CNTs in the
biomedical field is in gene therapy. CNTs have been shown
to be efficiently internalized by mammalian cells [3] and able
to deliver gene cargoes [4]. However, transfection efficiencies
obtained in cells and small animal models are not yet compa-
rable to those reached with other delivery systems, such as
viral vectors [5]. It is likely that the relatively low efficiencies
are due to inefficient penetration of barriers at systemic tis-
sue and cellular levels that the vector has to be able to over-
come in order to reach its target and deliver its cargo [6]. A
key barrier to overcome in order to obtain efficient gene
expression is intracellular trafficking of the internalized vec-
tor [7]. Nucleic acid degradation during passage through the
cellular internalization pathways is likely to play a key role
in the ability of any vector to deliver a functional nucleic acid
to its target in the nucleus (for DNA) or to the gene expression
machinery (for RNA) in the cytoplasm. However, most non-
viral vectors, including CNTs, have shown to be internalized
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by endocytosis [8] which leads to entrapment and degrada-
tion of the genetic material in lysosomes. Escape of delivered
cargo from the lysosomal degradative pathway is likely to be
crucial to development of therapeutic application of CNT
delivery [9]. Several strategies have been developed to over-
come the intracellular DNA degradative barrier for other nu-
cleic acid delivery systems based on the destabilization of
endosomal and lysosomal membranes [10]. For example,
addition of lysosomotropic compounds in the cultured media
has been reported to greatly enhance the transfection effi-
ciency [11]. These compounds are weak bases that become
protonated at the acidic pH inside the lysosomes and, in con-
sequence, cause a swelling and rupture of the endocytic ves-
icle, releasing delivered genetic material into the cytoplasm.
Carbon nanotubes can be exohedrically functionalized by
attaching different functional groups or cargoes to the exter-
nal walls [12,13], but can also be filled with different com-
pounds [14,15], although optimization of filling and release
remains problematic [16]. In this context, double-walled car-
bon nanotubes (DWCNTs) are a versatile material for a carrier
design as the outside can be functionalized without modify-
ing the integrity of the inner tube, leaving it intact for filling.
The toxicity of the DWCNTs used in this work has been inves-
tigated extensively in earlier work [3,17,18], as well as their
potential environmental impact [19,20]. Theoretical studies
have investigated the filling and loading on the external walls
of CNTs with different anticancer drugs [13,21] and subse-
quent release for therapeutic purposes [22]. However, the
loading of CNTs with a compound to be co-delivered with
plasmid DNA to improve gene delivery has not so far been
investigated. We report for the first time the loading of
DWCNTs with the lysosomotropic anti-malarial drug chloro-
quine and demonstrate its ability to enhance the cell trans-
fection efficiency.
2. Experimental
2.1. Materials
Chloroquine diphosphate salt, poly(Lys:Phe) 1:1 hydrobromide
(PLP), polyethylenimine (PEI), RNA frombaker’s yeastwerepur-
chased from Sigma. DSPE-PEG(2000)-amine (DSPEA-PEG) was
purchased from Avanti Polar Lipids. pGL3-control vector and
Bright-GloTM luciferase assay system were purchased from
Promega. Qiaprep Spin MiniPrep Kit was purchased from Qia-
gen. DC Protein Assay was purchased from Bio-Rad. Opti-
MEM I Reduced-Serum Medium (1x) and MEM medium were
purchased from Invitrogen.
2.2. Synthesis of DWCNTs
DWCNTs were produced by CCVD decomposition of CH4 over
Mg(1-x)CoxO solid solution, containing small addition of
molybdenum, as described earlier [23]. After the CCVD synthe-
sis, the remaining oxide material, as well as the unprotected
metal (Co, Mo) particles, were removed by treatment of the
sample with concentrated aqueous HCl solution. The acidic
suspension was filtered on 0.45 lm pore size cellulose nitrate
membrane (Whatman) andwashedwith deionizedwater until
neutrality. The resultingDWCNTs, denoted extractedDWCNTs
(raw DWCNTs), were then dried overnight in an oven, at 80 °C
[24]. High-resolution transmission electron microscopy
showed that a typical sample consists of ca. 80% DWCNTs,
the rest being SWCNTs (ca. 15%) and a few triple-walled carbon
nanotubes (ca. 5%). The diameter distribution of the DWCNTs
ranged from 0.5 to 2.5 nm for inner tubes and from 1.2 to
3.2 nm for outer tubes. The length of individual DWCNTs usu-
ally ranges between 1 and 10 lm, although bundles may be
much longer (up to 100 lm at least) [23].
Two different treatments of the raw DWCNTs were per-
formed (a) an oxidation treatment and, (b) an opening treat-
ment. These treatments were used to optimize the
chloroquine loading on DWCNTs and therefore, the loading
yield was compared for raw, oxidized and opened DWCNTs.
(a) Oxidation treatment: the walls of the DWCNTs were not
expected to be functionalized during the synthesis and cata-
lyst-elimination conditions [25]; so an additional post-synthe-
sis treatment was required, in order to obtain oxygen-
containing functional groups on the outer wall of the raw
DWCNTs. This was achieved with nitric acid treatment which
produces mainly carboxylic groups [26]. A sample of oxidized
DWCNTwas thus prepared by refluxing raw DWCNTs (30 mg)
in nitric acid solution (30 mL, 3 M), at 130 °C. After 24 h, the
obtained suspension was filtered and the DWCNTs were
washedwith deionized water until a neutral pH was obtained.
A ten-minute tip-sonication step in deionized water was used
to disperse the oxidized DWCNTs. After re-filtration, the so-
called oxidized DWCNTs were dried overnight in an oven at
80 °C. (b) Opening treatment: raw DWCNTs were also opened
by treatment with solid NaOH [27]. Briefly, raw DWCNTs
(30 mg) were intimately mixed in glove-box conditions with
NaOH (ca. 122.3 mg), with a purity of 98.5+% (Aldrich), in an
approximate molar ratio of 1:1.3 [28]. The grey mixture-pow-
der was then transferred into a quartz ampoule and sealed
under vacuum. It was finally placed in a tubular furnace
and heated at 3 °Cminÿ1 to 418 °C (100 °C above the melting
point of NaOH, 318 °C). The sample was kept for 240 min at
this temperature and it was then slowly cooled down to room
temperature at 1 °Cminÿ1. A black agglomerate with metallic
reflects was obtained, which was again ground in a mortar,
until a powder was obtained. In order to eliminate the excess
of NaOH (at the surface of the tubes), the resulting powder
was then transferred into a small quantity of deionizedwater,
sonicated for 1 min in a sonication bath, filtered and then
washedwith deionized water. A reflux step, under continuous
stirring in deionized water at 80 °C was used to eliminate the
remaining excess of NaOH. After 24 h, the obtained grey sus-
pension was filtered and the DWCNTs were washed with
deionized water, until the colour of the filtrate could no longer
be observed. The so-called opened DWCNTs were obtained
from the filtration-membrane and dried overnight in an oven,
at 80 °C.
2.3. Chloroquine loading of DWCNTs
About 15 mg of each non-loaded raw, oxidized and opened
DWCNTswere loaded in solutionwithanexcessof chloroquine
diphosphate salt [29,30]. This anti-malarial drug is very soluble
inwater (100 mgmLÿ1) and extremely sensitive to sunlight. For
the loadingof each typeofDWCNTs,we followed the samepro-
cedure. In a first step, three identical solutions were prepared:
chloroquine diphosphate salt (4750 mg) was quickly dissolved
in deionized water (50 mL) (30 s of bath sonication). Then,
DWCNTs (15 mg of raw or oxidized or opened) were added to
the corresponding solution and stirred 24 h at room tempera-
ture. The flasks were all the time protected from sunlight with
aluminiumfoil. Free chloroquinewas removedbyfiltrationand
subsequentwashing steps. After 24 h, the three solutionswere
filtered to obtain chloroquine-loaded raw, oxidized andopened
DWCNTs. The tubes werewashedwith few drops of deionized
water and then ethanol, followed by drying under vacuum at
room temperature.
2.4. Coating of DWCNTs with cationic polymers
Raw DWCNTs, oxidized DWCNTs (with HNO3, 3 M) and
opened DWCNTs (with NaOH) were coated with different
cationic polymers: polyethyleneimine (PEI), poly(Lys:Phe, 1:1)
(PLP) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-
N-[amino(polyethylene glycol) 2000 (DSPE-PEG-NH2). Each
kind of non-coated DWCNTs (1 mg) was respectively mixed
with the cationic polymer solution in deionized water (1 mL
of 2 mgmLÿ1 for PEI and 1 mL of 0.5 mgmLÿ1 of PLP and
DSPE-PEG-NH2). The mixtures were sonicated in a tip sonica-
tor (Soniprep 100W of output power, set at 20% of maximum
amplitude) for 100 s in 10 cycles of 10 s on 10 s off. The sus-
pensions were centrifuged at 5000 rpm for 3 min and the
supernatant was filtered in ultrafiltration tubes of 0.1 lm from
Millipore. The filtrates were washed 4 times with deionized
water (50 lL), resuspended in deionized water (0.5 mL) and
ultrasonicated for 20 s (2 cycles of 10 s on 10 s off).
2.5. Coating of DWCNTs with RNA
Raw DWCNTs, oxidized DWCNTs and opened DWCNTs were
treated with RNA. Each kind of DWCNTs (2 mg) were mixed
with RNA solution in deionized water (1 mL of 4 mgmLÿ1)
and ultrasonicated (Soniprep 100W of output power, set at
20% of maximum amplitude) for 100 s in 10 cycles of 10 s on
10 s off. Then, deionized water (1 mL) was added and the mix-
tures were sonicated in a 100W water bath for 1 h. The sus-
pensions were filtered on ultrafiltration tubes of 0.1 lm from
Millipore. Each filtrate was washed 3 times with deionized
water (50 lL) and resuspended in deionized water (1 mL).
2.6. Agarose gel electrophoresis for quantification of the
chloroquine-loading of DWCNTs
0.8% Agarose gel electrophoresis in TAE buffer (mixture of tris
base 40 mM, acetic acid 40 mM and EDTA 1 mM) was used to
characterize the chloroquine loading of the DWCNTs and the
release of the drug from the carbonnanotubes. Gel electropho-
resis was run for 30 min at 90 V with 40% sucrose solution in
deionised water as loading buffer (the final concentration of
sucrose in the loaded samples was 6.7%). Chloroquine on its
own was loaded in the gel as control to a concentration in the
range of (5–75) lM. Chloroquine-loaded raw, oxidized and
opened DWCNTs were also coated with RNA prior to electro-
phoresis. For this step, each kind of chloroquine-loaded
DWCNTs (2 mg) were mixed with RNA solution (1 mL of
4 mg mLÿ1) andultrasonicated for 100 s (Soniprep100 Wofout-
put power, set at 20%ofmaximumamplitude, 10 cyclesof 10on
and 10 s off). RNA-coated carbon nanotubes were well dis-
persed and no centrifugation was carried out so that the
amount of carbon nanotubes loaded onto the gel was accu-
rately known. The suspensions were filtered on 0.1 lm hydro-
philic PVDF filtration membranes and the solid was washed
with deionizedwater. Each solidwas resuspended in deionized
water (1 mL). For thequantificationof the chloroquine-loading,
each sample of RNA-coated DWCNTs (20 lL of 0.24 mgmLÿ1)
dispersed in deionized water and in 0.3% hydrochloric acid
weremixedwith the loading buffer (4 lL) and loaded into each
well.
2.7. Kinetics of chloroquine release from DWCNTs
Gel electrophoresis, as described above, was run for 30 min at
90 V with 40% sucrose as loading buffer. Filled DWCNTs were
functionalized by wrapping with the amphiphilic polypeptide
poly(Lys:Phe, 1:1). Each kind of chloroquine-loaded DWCNTs
(1 mg) was respectively mixed with poly(Lys:Phe, 1:1) (1 mL of
2 mg mLÿ1). The mixtures were ultrasonicated for 100 s (Soni-
prep 100 Wof outputpower, set at 20%ofmaximumamplitude,
10 cycles of 10 s on, 10 s off) and centrifuged at 100 rpm for
5 min. The supernatantswere filtered andwashedwith deion-
ized water on 0.1 lm filtration membranes. Each solid was
resuspended in deionized water (0.75 mL). The poly(Lys:Phe,
1:1)-coated chloroquine-loaded DWCNTs (300 lL of 60 lg mL
ÿ1) were mixed with universal buffer 0.1 M pH 4.8 or 7.4
(50 lL). Universal buffer was prepared from an equimolarmix-
ture of phosphoric acid, boric acid and acetic acid and adjust-
ing the pH with NaOH 1 M or HCl 1 M. The mixtures of
poly(Lys:Phe, 1:1)-coated chloroquine-loaded DWCNTs were
incubated in awater bath at 37 °C for 24 h.Aliquots (50 lL)were
removed after universal buffer addition (t = 0), and after
30 min, 60 min, 90 min, 2 h, 3 h, 24 h. The aliquotswere filtered
on 0.1 lm filtration membranes and the filtrate kept at ÿ4 °C
before electrophoresis. The gel was run for 30 min at 90 V.
2.8. Delivery of luciferase gene into HeLa cells
For the preparation of the transfectionmixtures, the appropri-
ate amount of PEI-coated DWCNTs (loaded or non-loadedwith
chloroquine)wasmixedwith the solution of pGL3 plasmid and
incubated for 30 min prior transfection. These DWCNTs-PEI-
pGL3 complex solutions (250 lL) were mixed with Opti-MEM
Reduced SerumMedia (Invitrogen) (250 lL) and supplemented
with 1% antibiotics (penicillin/streptomycin). HeLa cells were
cultured in 24-well plates in D-MEM (Invitrogen) without anti-
biotics until they reached 75% confluence. The cells were then
washedwithPBSand incubatedwith the transfectionmixtures
as described above for 4 h at 37 °C. After 4 h, 1 mL of MEM sup-
plementedwith 10% fetal bovine serum, 1%non essential ami-
no acids and 1% antibiotics (penicillin/streptomycin) was
addedwithout removing the transfectionmixture and the cells
were incubated overnight in this medium. The medium was
then replaced by fresh media and the cells were incubated for
48 h to express the luciferase gene.
2.9. Luciferase assay
Cells were washed twice with PBS and incubated for 15 min
with lysis buffer (100 lL). After scraping the cells off the dish,
the lysate was centrifuged for 15 s at 12,000g at room temper-
ature and the supernatant was transferred into a new tube
and kept on ice to perform the luciferase assay. Luciferase
substrates (Bright-GloTM Luciferase Assay System from Prome-
ga) (50 lL) was mixed with the lysate (50 lL) and lumines-
cence signal was recorded in a well plate reader and
averaged over 5 min. Total protein was determined in the cell
lysate by the Bio-Rad DC Protein Assay which is a colorimetric
method based on the Lowry assay [31].
2.10. MTT cell viability assay
Cells were seeded in a 96-well plate at 5000–10000 cells per
well in 200 lL of media and incubated overnight. One hundred
microliter of media ± RNA-coated oxidized or open non-
loaded and loaded DWCNTs was added to each well and cells
incubated for three days. MTTwas added to each well (10 lL)
and incubated at 37 °C for 3 h. The media was removed and
200 lL of DMSO was added per well to dissolve the formazan
crystals. Finally, the absorbance values at 570 nm (working
wavelength) and 630 nm (reference wavelength) were used
as a measurement of cell viability.
2.11. Characterization of DWCNTs
Raman spectroscopy: Raman spectra of the non-loaded
DWCNTs were obtained at 633 nm, with a LabRAM HR 800
(Jobin and Yvon) spectrometer. Chemical analysis: Elemental
analysis was performed by atomic emission spectroscopy
(AES). HR-TEM: The HR-TEM was carried out using a high res-
olution transmission electron microscope JEOL-JEM-2100F
(operated at 200 kV). For sample preparation, chloroquine-
loaded DWCNTs were briefly dispersed in ethanol. A few
drops of each suspension were then deposited onto a
300 mesh Lacey copper TEM grid placed on absorbing paper.
3. Results and discussion
3.1. Synthesis and characterization of the chloroquine-
loaded DWCNTs
Thepurpose of thiswork is to synthesize a gene delivery vector
able to carry and co-deliver a lysosomotropic drug in order to
enhance the transfection efficiency. For this purpose, DWCNTs
were selectedbecause of their versatility, as both their external
wall and inner tube can be functionalized for loading with dif-
ferent compounds, and because of their no toxicity at concen-
trations potentially useful for biomedical applications.
Compared to common sources, they present the advantage of
being perfectly characterized in terms ofmorphology and pur-
ity, as well as toxicity thanks to earlier studies [3,17–20]. They
also offer a better chemical and mechanical stability as com-
pared to single-walled carbon nanotubes (SWCNTs) and thus
represent the optimal choice in termsof drug/containerweight
ratio. DWCNTswere coatedwith a cationic polymer in order to
bind plasmid DNA through ionic interactions, and loadedwith
a lysosomotropic drug to obtain an efficient gene delivery vec-
tor. The selected lysosomotropic drug was chloroquine, that
promotes a lysosomal escape of the delivery vector avoiding
the DNA degradation in the cellular compartment. In this sec-
tion, DWCNTs were tested first for their ability to be loaded
with chloroquine. Raw DWCNTs were synthesized as previ-
ously described [23] and were subjected to two different types
of treatments: (a) an oxidation treatment with 3 M nitric acid
which generates carboxylic acid groups on the CNTwalls but
also opens the tubes and, (b) a treatment with NaOH which
opens the tubes but does not functionalize them. The three
types of DWCNTs (raw, oxidized and opened) were compared
in their ability to be loaded with chloroquine in order to select
the optimum starting DWCNT material for drug loading and
subsequent release. For simplicity, the different types and
combinations of functionalized DWCNTs that will be used
throughout themanuscript are described in Table 1. According
to this table, the three types of DWCNTs that will be compared
for chloroquine loading are the ones denoted as ((1), (2) and (3)).
As prepared (1)–(3) DWCNTs were first characterized by
Raman Spectroscopy. As it can be seen in Fig. 1, differences
in the Raman D and G bands, which are an indicator of the le-
vel of defects of the sample [31], are observed. In this way, an
increasing ID/IG intensity ratio corresponds to a higher level
of defects and a decreasing ID/IG ratio corresponds to a higher
level of structural quality. The oxidation treatment or raw
DWCNT produces an increase in the ID/IG ratio (ID/IG ratio in-
creases from 0.18 for (1) to 0.44 for (2)). Oxidation with nitric
acid is known to remove impurities from CNTs (such as amor-
phous carbon and metals), and therefore this increase in ID/
IG ratio is indicating an increase in the defects in the carbon
material which is also consistent with previous studies that
have demonstrated that this treatment increases defects in
carbon compounds [32]. Besides, NaOH treatment of raw
DWCNTs produces a decrease in the ID/IG ratio from 0.18
for (1) to 0.10 for (3). This is consistent with previous studies
that have demonstrated that treatment with molten NaOH
is a recognized single step process for the simultaneous puri-
fication and opening of raw carbon nanotubes [33].
Chloroquine diphosphate salt (C18H26ClN3·2H3PO4) was
used for the loading of DWCNTs samples (1)–(3). Chloroquine
is a hydrophobic weak base with a quinoline aromatic ring
that can interact with CNTwalls, both the external and the in-
ner walls, through hydrophobic interactions (p–p stacking
interactions). The DWCNTs used for this study have a wide
diameter (diameter distribution of the DWCNTs ranged from
0.5 to 2.5 nm for inner tubes and from 1.2 to 3.2 nm for outer
tubes) in order to increase the surface area and, therefore the
ability to load the nanotubes with the drug. Loading of the
drug was attempted by incubation of DWCNTs samples (1)–
(3) in chloroquine diphosphate salt aqueous solution for
24 h at room temperature. Washing by filtration on a polypro-
pylene membrane (0.45 lm) was used to remove free chloro-
quine. In this way, chloroquine-loaded DWCNTs samples
(4)–(6) were obtained. After recovery of the DWCNTs, chemical
analysis of the proportion of chlorine in the CNTs was used to
quantify the chloroquine content of each preparation. As it
can be seen in Table 2, both samples (5) and (6) have a similar
and higher chloroquine content than sample (4). Energy-dis-
persive X-ray spectroscopy (EDX) confirmed also the presence
of traces of chlorine, nitrogen, phosphorus and oxygen in
chloroquine-loaded DWCNTs which is in agreement with
the presence of chloroquine diphosphate on the CNTs (Sup-
plementary material Figs. S1 and S2). Additionally, high-reso-
lution transmission electron microscopy (HR-TEM) was used
to study the structure of chloroquine-loaded DWCNTs. Fig. 2
shows a typical HR-TEM image of sample (5). As it can be
seen, apparently poorly organized material mainly around
individual tubes is apparent. Most of the DWCNTs are covered
with some amorphous coating, which could correspond to
oxidation debris created by post-synthesis treatment with
HNO3, but the presence of adsorbed chloroquine or even chlo-
roquine filling inside the inner tube cannot be ruled out from
these images given the high loading of chloroquine on the
samples (see Table 2). In fact, chloroquine cannot only be ad-
sorbed on the DWCNTs but is likely to be also located within
the triangular channels formed between the nanotubes in a
compact bundle. These channels are actually open and there-
fore, can be filled with a potential facile release. Conse-
quently, it can be concluded that most of the chloroquine is
loaded on the external walls of the DWCNTs both in debun-
Table 1 – Different types of DWCNTs used in this work.
Construct
number
Chloroquine loading procedure Chloroquine loading DWCNT coating pGL3 plasmid loading
(1) Raw DWCNT No No No
(2) Oxidized DWCNT No No No
(3) Opened DWCNT No No No
(4) Raw DWCNT Yes No No
(5) Oxidized DWCNT Yes No No
(6) Opened DWCNT Yes No No
(7) Raw DWCNT No RNA No
(8) Oxidized DWCNT No RNA No
(9) Opened DWCNT No RNA No
(10) Raw DWCNT Yes RNA No
(11) Oxidized DWCNT Yes RNA No
(12) Opened DWCNT Yes RNA No
(13) Oxidized DWCNT Yes PLP No
(14) Opened DWCNT Yes PLP No
(15) Oxidized DWCNT No DSPEA-PEG Yes
(16) Oxidized DWCNT Yes DSPEA-PEG Yes
(17) Oxidized DWCNT No PLP Yes
(18) Oxidized DWCNT Yes PLP Yes
(19) Oxidized DWCNT No PEI Yes
(20) Oxidized DWCNT Yes PEI Yes
(21) Opened DWCNT No PEI Yes
(22) Opened DWCNT Yes PEI Yes
(23) Raw DWCNT No PEI Yes
(24) Raw DWCNT Yes PEI Yes
Fig. 1 – Raman spectra of the non-loaded DWCNTs. Comparison between raw (–––) and oxidized (- - -) DWCNTs.
dled and bundled nanotubes. In contrast, Fig. 2b shows a HR-
TEM image of sample (6). Both bundles and individual tubes
with undamaged outer wall are clearly seen. Here again, the
possible presence of chloroquine adsorbed on the DWCNTs
outer wall is proposed, especially because NaOH treated sam-
ples are not coated by amorphous carbon. Here again, some
filling inside the DWCNT cannot be ruled out.
Chloroquine-loaded DWCNTs need to be coated with a
polymer in order to be dispersed in aqueous media and to
be able to bind DNA for the gene delivery purposes of this
work. As chloroquine seems to be mainly adsorbed on the
DWCNTswalls, an important aspect to be studied is the effect
of this polymer coating on the retention of the chloroquine
loading of the DWCNTs. This coating has an effect on the dis-
placement of chloroquine adsorbed on the external wall of
the DWCNTs by the coating polymer. However, chloroquine
that may be loaded within the triangular lattice of compact
bundles should not be affected. Additionally, the polymer
coating procedure includes further washing steps that can re-
duce the total chloroquine loading on DWCNTs. Conse-
quently, the effect of the coating procedure on the retention
of the chloroquine loading has to be evaluated. RNAwas used
as coating agent for the dispersion with high yield and stan-
dardization of DWCNTs samples (see Supplementarymaterial
Fig. S3) [34].
DWCNT preparations, (4)–(6) were coated with RNA
(obtaining samples (10)–(12)) alongside control samples of
DWCNTs non-loaded with chloroquine (1)–(3) (obtaining sam-
ples (7)–(9)). Gel electrophoresis was used to quantify the
chloroquine content of the DWCNT preparations (see Supple-
mentary material Fig. S4). Positively charged chloroquine mi-
grates to the cathode and can be directly detected in the gel
thanks to its intrinsic fluorescence, both qualitatively from
its Rf (retention factor) and quantitative from its band inten-
sity [35]. A known amount of RNA-coated DWCNTs can be
loaded on the gel so that the released chloroquine can be
accurately detected and quantified on the gel as the intensity
of the chloroquine band is proportional to the concentration
of the drug. No chloroquine bandwas detected for non-loaded
DWCNTs samples ((7)–(9)) being only detected for chloro-
quine-loaded DWCNTs samples ((10)–(12)), as expected. Re-
lease of chloroquine from loaded DWCNTs was clearly
promoted in acidic conditions (Fig. 3 lane c) compared to neu-
tral pH (Fig. 3 lane b). This can be accounted for tendency of
the hydrophobic nanotubes to repel the protonated nitrogen
of the quinoline ring of chloroquine at acidic pH leading to
the drug’s rapid release from the tubes and a consequent
sharp band on electrophoresis. In contrast, the samples
loaded at neutral pH generated a long tail of chloroquine
through the gel which is consistent with greater retention of
the drug on the nanotubes and slower release throughout
the electrophoresis procedure. The quantification of the load-
ing of chloroquine was performed using the chloroquine band
obtained at acidic pH as it corresponds to a complete chloro-
quine release from the loaded DWCNTs. This quantification is
shown in Table 2. As it can be seen, the chloroquine loading
on DWCNTs decreases after the polymer coating as expected.
In addition, DWCNTs preparations (11) and (12) retained the
loaded chloroquine on the nanotubes after polymer coating
with higher yield. Therefore, DWCNTs (5) and (6) are the best
starting material for obtaining optimum chloroquine loading
after polymer coating. Cell viability assays were performed
with samples (7)–(12) in order to investigate their cytotoxicity
and select the best material for the biological applications of
this work (see Supplementarymaterial Section S4). Sample (5)
was identified as the one that showed the lowest cytotoxicity.
Therefore, sample (5), which corresponds to chloroquine-
loaded oxidized DWCNTs, was selected as optimum for the
main purpose of this work and will be used in the following
studies.
3.2. Evaluation of chloroquine-loaded DWCNTs as drug
delivery system
Chloroquine-loaded DWCNTs were evaluated as drug delivery
system. For these purpose, we investigated cytotoxicity of the
chloroquine-loaded DWCNTs using the HeLa human cell line
as target and the MTT cell viability assay in which the MTT
substrate (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoli-
um bromide, a tetrazole) is reduced to purple formazan in
the mitochondria of living cells. RNA-coated DWCNTs both
chloroquine-loaded (sample (11)) and non-loaded as a control
(sample (8)) were used in these studies. RNA gives a high dis-
persion yield (between 1 and 2 orders of magnitude higher
than with the other coatings) and allowed us the testing of
cytotoxicity for a wider range of DWCNTs concentrations.
As it can be seen in Fig. 4a, non-loaded DWCNTs showed no
cytotoxicity in the range of concentrations studied. However,
chloroquine-loaded DWCNTs presented a higher cytotoxicity
(LD50 value of 190 lg mL
ÿ1). This higher cytotoxicity of chloro-
quine-loaded tubes compared to non-loaded ones was pre-
sumably due to the release of the drug, which is cytotoxic
on its own (Fig. 4b). Note however that free chloroquine is
cytotoxic at concentrations much higher than the total chlo-
roquine concentration in the DWCNTs suspensions. The total
dose of chloroquine carried by the DWCNTs was calculated
(see Table 2) and depicted in Fig. 4b, showing a shift of one or-
der of magnitude towards lower concentrations compared to
Table 2 – Quantification of chloroquine of DWCNTs samples by elemental analysisa (before polymer
coating) and electrophoresisb (after polymer coating of DWCNTs).
DWCNT sample Chloroquine (wt.%)a DWCNT sample Chloroquine (wt.%)b
(7) 53.8 (10) 2.0
(8) 59.0 (11) 10.5
(9) 73.2 (12) 12.9
a Quantification of chloroquine of DWCNTs samples by elemental analysis (before polymer coating).
b Electrophoresis (after polymer coating of DWCNTs).
free drug. As it can be seen, DWCNTs are able to deliver the
drug into the cells with higher efficiency than free drug
(LD50 free chloroquine 46 lg mL
ÿ1, LD50 chloroquine loaded
on DWCNTs 16 lg mLÿ1), proving the efficiency of DWCNTs
as drug delivery system.
We next investigated the mechanism of drug release from
the DWCNTs. The mechanism of entry of the DWCNTs in
HeLa cells was studied showing internalization by an endo-
cytic pathway (see Supplementarymaterial Section S5), which
is in agreement with previous studies [8]. When the DWCNTs
are internalized by this mechanism, they are brought into the
cytoplasm (pH 7.4) inside an endosome that finally matures
into a lysosome, an acidic cellular compartment (pH 4.8). As
it was shown in Fig. 3, chloroquine release was promoted at
acidic pH, the drug being retained on the loaded DWCNTs at
neutral pH. The kinetics of the release of chloroquine from
DWCNTs was therefore investigated at neutral and acidic
pH. Chloroquine-loaded DWCNTs coated with a cationic poly-
mer (to simulate the future gene delivery conditions) were
used for this study (sample (13)). The chloroquine-loaded
DWCNTs were incubated at 37 °C (physiological temperature)
at pH 4.8, corresponding to the typical pH for the lysosomal
compartment, and pH 7.4, corresponding to cytoplasmic pH
before electrophoresis. Aliquots of these incubation mixtures
were taken at different times, treated as described in the
experimental section, and run in agarose gel electrophoresis
(pH 4.8 Fig. 5a; pH 7.4 Fig. 5b). The intensity of the chloroquine
bands was quantified by pixel intensity/counting using Ima-
geJ imaging software (Fig. 5c). As it can be seen, the kinetics
of chloroquine release from the DWCNTs was clearly acceler-
ated at lysosomal pH (a mathematical model was developed
for the kinetic description of chloroquine release from the
DWCNTs that fitted the experimental kinetic curves (Supple-
mentary material Section S6)). This fact confirms the trig-
gered release of chloroquine from DWCNTs by a pH
decrease. In this way, the results obtained in Fig. 4b are con-
firmed by this mechanism. The pH-triggered drug delivery
from by DWCNTs in the lysosomes produces higher levels of
the drug inside the cell, reaching cytotoxic values at drug con-
centrations lower than for free drug. The enhanced release of
the drug at acidic pH from DWCNTs is clearly an advantage
for gene therapy. Chloroquine remains on the DWCNTs at
Fig. 2 – HR-TEM images of chloroquine loading within: (a)
oxidized DWCNT (sample (5)). The black arrows indicate
discontinuous filling with apparently poorly organized
material on/in individual DWCNTs; some amorphous
coatings on the outer walls are visible, as well as a
destroyed tip of an oxidized DWCNT (white arrow); (b)
opened DWCNTs (sample (6)): the black arrows indicate the
probable presence of poorly organized chloroquine
diphosphate salt around the DWCNTs or even possibly
inside.
Fig. 3 – Agarose gel electrophoresis pattern of chloroquine-
loaded DWCNTs. (A) agarose gel: lane a: free chloroquine
75 lM, lane b: RNA-coated chloroquine-loaded DWCNTs
0.52 mgmLÿ1 dispersed in deionized water, lane c: RNA-
coated chloroquine-loaded DWCNTs 0.52 mgmLÿ1
dispersed in hydrochloric acid 0.3%. (B) Profile of the
chloroquine bands in the different lanes (a–c). Sample (11) is
shown in this figure as a model.
physiological conditions and the internalization of the drug-
loaded DWCNTs inside the acidic lysosomes of the cells trig-
gers the release of the drug into the cells. Therefore, chloro-
quine is only released from DWCNTs in the targeted cellular
compartment, the lysosome. The released drug being co-
delivered with a gene would lead to enhanced gene transfec-
tion efficiencies given its lysosomotropic properties. These
properties were therefore further explored in the following
section.
3.3. Evaluation of chloroquine-loaded DWCNTs as gene
delivery system
We next investigated the ability of chloroquine-loaded
DWCNTs to deliver a functional gene encoding the enzyme
luciferase. To interact with cells and deliver genes the nano-
tubes needed to be funtionalized to be able to bindDNA. In this
way, DWCNTswere coatedwith different cationic polymers in
order to disperse them in aqueousmedia, to test their ability in
bindingnegatively chargedplasmidDNA (pGL3plasmidencod-
ing luciferase gene), and in evaluating these complexes
(DWCNT-cationic polymer-pGL3, both chloroquine-loaded
andnon-loaded) in transfectingHeLacells.CoatingofDWCNTs
with the cationic polymers 1,2-distearoyl-sn-glycero-3-phos-
phoethanolamine-N-[amino(polyethylene glycol)2000]
(DSPEA-PEG), (Poly(Lys:Phe, 1:1) (PLP) and polyethyleneimine
(PEI) was tested (samples (15)-(20)). Good dispersion of
DWCNTs was obtained with these coatings being the com-
plexes able to bind the plasmid DNAwith high efficiency (see
Supplementary material Section S3). These complexes were
tested to study their efficiency in delivering pGL3 plasmid
and the effect of their chloroquine loading on the transfection
efficiency.
As it can be seen in Fig. 6, choroquine-loaded DWCNTs
coated with PEI showed the highest transfection efficiencies
when compared with their controls (non-loaded DWCNTs,
naked plasmid and free PEI, with free chloroquine and no free
chloroquine addition). Furthermore, the ability of the coating
polymer to bind plasmid DNAhas an effect on the transfection
efficiency. The transfection efficiencies for PEI-coated (sample
(20)), PLP-coated (sample (18)) andDSPEA-PEG-coatedDWCNTs
(sample (16)) were in the relative efficiencies 1:0.2:0.07 at the
optimumconditions,which is related to the relativeDNAbind-
ing properties of DWCNTs coated with the different cationic
polymers (1.0:0.16:0.037 for PEI-coated, PLP-coated and
DSPEA-PEG-coated DWCNTs, respectively (see Supplementary
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Fig. 5 – Kinetics of chloroquine release from chloroquine-
loaded DWCNTs vs. pH. (a: pH 4.8, b: pH 7.4) in universal
buffer 0.1 M and at 37 °C (PLP-coated oxidized DWCNT
concentration 1.14 mgmLÿ1, Sample (13) was used in this
study; PLP was selected as cationic polymer as it gave the
best dispersion conditions of oxidized DWCNTs and
therefore, the best accuracy and sensitivity for the
chloroquine detection. Furthermore, the cationic polymer
simulates the in vitro drug release conditions that will be
tested. In all samples, sucrose at 6.67% was added as
loading solution and the gel was run at 90 V for 30 min.
Agarose gel electrophoresis of the permeates of the aliquots
taken and filtered at 0 min, 30 min, 60 min, 90 min, 2 h, 3 h
and 24 h. The quantification of the chloroquine bands of (a)
and (b) is shown in (c) at pH 4.8 (curve a, corresponding to
Fig. 5a) and pH 7.4 (curve b, corresponding to Fig. 5b); the
intensity band was normalized by the maximum intensity
band value. Data were fitted using a mathematical model
(Supplementary material).
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Fig. 4 – MTT cell viability tests with of HeLa cells treated
with non-loaded oxidized DWCNTs (sample (8)) ((a) dotted
lines) and chloroquine-loaded oxidized DWCNTs (sample
(11)) ((a) black solid lines). All DWCNTs samples were coated
with RNA prior to the assay. The effect of free chloroquine is
shown in ((b) black line) compared to chloroquine loaded on
oxidized DWCNTs ((b) grey line).
material). There was a clear enhancement of transfection effi-
ciency by using chloroquine-loaded DWCNTs, of about two or-
ders of magnitude when compared with controls. Note that
this result was obtained at a chloroquine concentration in
the entire transfection mixture lower than 1 lM (estimated
from the DWCNT concentration in the transfection mixture
and loading yield of the nanotubes with chloroquine) that
wasmuch lower than the concentrationnormally added to cul-
ture media as free drug for optimum transfection (of 25–
100 lM) [36–38]; andsowashighlyunlikely tobedue to leeching
out of the chloroquine prior to entry of CNTs inside cells. The
other forms of DWCNTs assayed for optimizing chloroquine
loadingwere also tested to investigate the effect of chloroquine
loading on DWCNTs on the transfection efficiency. As it can be
seen, as the chloroquine loading increases the transfection
efficiency increases (chloroquine loading are in the order
(24) < (20) < (22) corresponding to opened < oxidized < raw
DWCNTs). However, as explained in Section 3.5, sample (20)
showed the lowest cytotoxicity and therefore, it was selected
as optimum. In addition, theseDWCNTshowedno cytotoxicity
at the concentration levels needed for optimum gene delivery
(see Supplementary material Section S4). In conclusion,
chloroquine-loadedoxidizedDWCNTs coatedwith PEI (sample
(20) were selected as optimum gene delivery system. The over-
all approach of this methodology is illustrated in Fig. 7. It is
therefore highly likely that the enhancement of transfection
efficiency was due to the release of chloroquine from the
loaded tubes on their capture into lysosomes and subsequent
chloroquine-mediated promotion of lysosomal escape for the
DNA cargo. It seems likely that the released PEI-plasmid com-
plexes are then able to cross the nuclear envelope [39] leading
to efficient plasmid transcription and subsequent translation.
4. Summary
These studies have demonstrated a new methodology for im-
proved gene delivery based on the loading of DWCNTs with
the lysosomotropic compound chloroquine capable of pro-
moting escape of the DNA cargo from lysosomes. Chloroquine
is an established anti-malarial drug that is administered to
thousands of patients each year, so its toxicological proper-
ties are already well characterized. Acid treated (oxidized)
DWCNTs coated with PEI and loaded with chloroquine
showed the best results for gene delivery. Cell viability tests
showed no cytotoxicity of the functionalized DWCNTs at con-
centrations needed for optimum gene delivery. The triggered
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Fig. 6 – Luciferase expression (measured as relative luminescence units (RLU) per total lg of protein) from pGL3 plasmid
transfected by DWCNTs without (grey bars) and with (black bars) chloroquine loading. Naked pGL3 plasmid and PEI-pGL3
complexes (PEI 0.001% (w/w) without (dotted grey bars) and with 75 lg mLÿ1 chloroquine (dotted black bars) in the
transfection media are shown as controls. 75 lg mLÿ1 of free chloroquine was the concentration for optimum transfection in
HeLa cells; in addition nor luciferase expression was obtained for lower free chloroquine concentrations neither for other PEI
concentrations (0.01% (w/w) and lower). For transfection with DWCNTs, non-loaded oxidized DWCNTs coated with different
cationic polymers and complexed with pGL3 plasmid (samples (15), (17) and (19)) in the optimum conditions (For PEI-coated
DWCNTs 6 lg mLÿ1 of DWCNTs were used; for PLP-coated and DSPEA-PEG-coated DWCNTs 12 lg mLÿ1 of DWCNTs were
used) were used as controls (grey bars). Transfection efficiencies of the respective chloroquine-loaded oxidized DWCNTs
coated with the different cationic polymers and complexed with pGL3 plasmid (samples (16), (18) and (20)) are depicted in
black bars. Transfection efficiencies of chloroquine-loaded and non-loaded raw and opened DWCNTs coated with PEI and
complexed with pGL3 plasmid (samples (21)–(24)) are also depicted (DWCNTs concentration 6 lg mLÿ1). pGL3 plasmid
concentration in the transfection mixtures was 20 ng lLÿ1. Lipofectamine was used as positive control to assess the
effectiveness of the gene delivery vector based on DWCNTs; the system based on DWCNTs reached in the optimum
conditions around 10% of the transfection efficiency of lipofectamine (data not shown).
release of chloroquine from the DWCNTs in the lysosomes
was also demonstrated, together with the use of the DWCNTs
as a dual drug and gene delivery system. These results sup-
port the potential applications of chloroquine-loaded CNTs
for gene therapy.
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